Lenka Abhishek, Jankovic Joseph
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX.
Neurol Clin Pract. 2024 Aug;14(4):e200308. doi: 10.1212/CPJ.0000000000200308. Epub 2024 May 16.
The term "extrapyramidal system/symptoms/signs" and the acronym "EPS" have been abundantly used in neurology and psychiatry literature for more than a century. However, EPS has been increasingly criticized, especially by movement disorder neurologists, for its lack of clinical, anatomical, and physiologic definition. Contrary to traditional assumptions, pyramidal and extrapyramidal systems are not mutually exclusive. The acronym EPS, commonly used to denote drug-induced movement disorders, lacks specificity in conveying the nature and severity of these and other movement disorders. Consequently, we propose that the term is retired from scientific literature and that clinicians use specific phenomenologic descriptors for the various hypokinetc and hyperkinetic movement disorders.
“锥体外系/症状/体征”这一术语以及首字母缩写词“EPS”在神经学和精神病学文献中已被广泛使用了一个多世纪。然而,EPS越来越受到批评,尤其是运动障碍神经学家,因为它缺乏临床、解剖学和生理学定义。与传统观念相反,锥体系统和锥体外系并非相互排斥。通常用于表示药物引起的运动障碍的首字母缩写词EPS,在传达这些及其他运动障碍的性质和严重程度方面缺乏特异性。因此,我们建议该术语从科学文献中停用,临床医生对各种运动减少和运动增多性运动障碍使用特定的现象学描述词。